Discover 561 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 561
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Richmond VA, Charlottesville VA, Falls Church VA,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
US National OCS Heart Perfusion (OHP) Registry
for
Heart Transplant
Location: Richmond VA, Durham NC, Chapel Hill NC, Pittsburgh PA,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05915299
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
for
Kidney Transplant Rejection
Location: Richmond VA, Baltimore MD, Cleveland OH, Detroit MI,
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT04239703
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Richmond VA, Charlottesville VA, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
for
Chemotherapy-induced Peripheral Neuropathy
Location: Richmond VA, Baltimore MD, Philadelphia PA,
Sponsor: Disarm Therapeutics
Sex: All
Age: 18+
Code: NCT03997981
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Richmond VA, Virginia Beach VA, Washington D.C. DC,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for
Metastatic Non Small Cell Lung Cancer
Location: Richmond VA, Chapel Hill NC, Camden NJ,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT04614103
Phase2, Recruiting
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
for
Kidney Cancer
Location: Richmond VA, San Diego CA, Los Angeles CA
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Richmond VA, Durham NC, Pittsburgh PA, New York NY,
Sponsor: Ansun Biopharma, Inc.
Sex: All
Age: 0+
Code: NCT03808922
Phase3, Recruiting
Pulmonary Hypertension Association Registry
for
Pulmonary Arterial Hypertension,
Location: Richmond VA, Charlottesville VA, Norfolk VA,
Sponsor: Pulmonary Hypertension Association, Inc.
Sex: All
Age: 0+
Code: NCT04071327
Recruiting
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
for
Painful Peripheral Neuropathy,
Location: Richmond VA, Pittsburgh PA, New York NY, Rochester NY,
Sponsor: University of Rochester
Sex: All
Age: 18 - 70+
Code: NCT06614322
Phase2, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Richmond VA, Philadelphia PA, New York NY, Manhasset NY,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase3, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: Richmond VA, Philadelphia PA, New York NY, Montreal,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase1, Phase2, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Richmond VA, Falls Church VA, Winston-Salem NC,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Phase3, Recruiting
Pelacarsen Roll-over Extension Program
for
Atherosclerotic Cardiovascular Disease
Location: Richmond VA, Hopewell VA, Oxon Hill MD, Falls Church VA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06875973
Phase3, Recruiting
Nimodipine Variability in SAH
for
Subarachnoid Aneurysm Hemorrhage,
Location: Richmond VA, Toronto, Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT07065903
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Richmond VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Richmond VA, New York NY, Toronto, Louisville KY,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase3, Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Richmond VA, Durham NC, Charlotte NC, New York NY,
Sponsor: Tufts Medical Center
Sex: All
Age: 40+
Code: NCT06365060
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: Richmond VA, Durham NC, Philadelphia PA, West Orange NJ,